Although CD74 overexpression is mostly associated with hematologic malignancies, it has also been reported in non‐hematopoetic cancers such as gastric, renal, urinary bladder, non‐small cell lung cancer certain sarcomas and glioblastomas [53, 54, 55, 56, 57]. This evidence concerns the gene CD74 and hematologic disorder.